The Valley Desk

ArticleJournal of medicinal chemistryPublished

Discovery of MK-1468: A Potent, Kinome-Selective, Brain-Penetrant Amidoisoquinoline LRRK2 Inhibitor for the Potential Treatment of Parkinson's Disease

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Merck & Co. Affiliation source

Institution
Merck & Co.

Publication record

Type
Article
Venue
Journal of medicinal chemistry
Published
Subject terms
Brain; Humans; Parkinson Disease; Ion Channels; Protein Kinase Inhibitors; Mutation; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
PubMed ID
37861679
Added to directory
Source checked

Report a correction or request removal